Literature DB >> 12014779

Quetiapine-associated hyperglycemia and hypertriglyceridemia.

Steven E Domon, Christopher S Cargile.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12014779     DOI： 10.1097/00004583-200205000-00004

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  8 in total

1.  Atypical antipsychotic-induced diabetes mellitus in child and adolescent psychiatry.

Authors:  Dan Cohen; Saskia Huinink
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 2.  Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Authors:  John W Newcomer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.

Authors:  Paz Toren; Sharon Ratner; Nathaniel Laor; Abraham Weizman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Lipid effects of psychiatric medications.

Authors:  Junzo Watanabe; Yutaro Suzuki; Toshiyuki Someya
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

Review 5.  [Diabetes mellitus as a complication of treatment with atypical neuroleptics. Possible pathomechanisms and treatment recommendations].

Authors:  H Jahn; T Schneider
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

Review 6.  Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

Authors:  Kristina Melkersson; Marja-Liisa Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine.

Authors:  Cüneyt Unsal; Yakup Albayrak; Neslihan Albayrak; Murat Kuloglu; Kenji Hashimoto
Journal:  Neuropsychiatr Dis Treat       Date:  2013-10-11       Impact factor: 2.570

Review 8.  Weight gain and metabolic issues of medicines used for bipolar disorder.

Authors:  Andrea Fagiolini; K N Roy Chengappa
Journal:  Curr Psychiatry Rep       Date:  2007-12       Impact factor: 8.081
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.